Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07668414 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Name: A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide — clinical trial record (NCT07668414)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: AMAZE 7

StatusNot Yet Recruiting

PhasePhase 3

SponsorNovo Nordisk A/S

Started2026-09-22

View on ClinicalTrials.gov ↗

The purpose of this study is to find out if zenagamtide is safe and effective for treating participants who have excess body weight compared to treatment with semaglutide.

Amendment history 1 change detected by DataLookout

2026-08-26

Trial sites reduced: 46 → 43 locations

Trial Details

NCT Number	NCT07668414
Lead Sponsor	Novo Nordisk A/S
Conditions	Overweight, Obesity
Enrollment	650 participants
Start Date	2026-09-22
Primary Completion	2028-10-10 (estimated)
Study Completion	2028-10-10 (estimated)
Updated on ClinicalTrials.gov	2026-08-25